Eladur(神経因性疼痛):医薬品市場予測及び分析(~2022)

調査会社GlobalData社が発行したリサーチレポート(データ管理コード:GDHC410DFR)
◆英語タイトル:Eladur (Neuropathic Pain) - Forecast and Market Analysis to 2022
◆発行会社/調査会社:GlobalData
◆商品コード:GDHC410DFR
◆発行日:2014年4月30日
◆調査対象地域:グローバル
◆ページ数:86
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD3,495 ⇒換算¥394,935見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD6,990 ⇒換算¥789,870見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD10,485 ⇒換算¥1,184,805見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Eladur(神経因性疼痛):医薬品市場予測及び分析(~2022)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Eladur (Neuropathic Pain) – Forecast and Market Analysis to 2022

Summary

Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which is a consequence of trauma, injury, or inflammation. The main difference between neuropathic and nociceptive pain is the absence of a continuous nociceptive input in neuropathic pain. Although the term neuropathic pain is used to describe a wide range of pain syndromes with varying etiologies, this report focuses on 3 distinct forms of NP: Painful diabetic neuropathy, Postherpetic neuralgia and trigeminal neuralgia. The main classes of drugs used to treat these three neuropathic pain indications include anticonvulsants, antidepressants, opioids and topical treatments. However, despite the availability of multiple pain medications only 50% of patients respond to any given drug and there are numerous the side effects associated particularly with systemically administered drugs, that reduce their tolerability. New treatments will target some key unmet needs in terms of efficacy and tolerability, but opportunities will remain for drugs that can more reliably eradicated NP in targeted patient populations, as well as offering an improved safety profile.

Eladur is a transdermal bupivacaine patch developed by Durect Corporation that is intended to deliver bupivacaine for up to three days from a single application. Durect had been engaged in a licensing agreement with Pfizer (through its subsidiary, King Pharmaceuticals) to develop and commercialize Eladur, but in February 2012, Pfizer notified Durect that it was terminating this agreement and returned all the rights to Durect. In January 2014, Durect established another development and commercialization agreement for Eladur, this time with Impax Laboratories.

Scope

- Overview of Neuropathic pain, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on Eladur acetate including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for Eladur acetate for the top six countries from 2012 to 2022.
- Sales information covered for the US, France, Germany, Italy, Spain and the UK.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of the competition by understanding the changing competitive landscape for Neuropathic pain
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of Eladur acetate performance
- Obtain sales forecast for Eladur acetate from 2012-2022 in the top six countries (the US, France, Germany, Italy, Spain and the UK).

*** レポート目次(コンテンツ)***

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 10
2.1 Catalyst 10
2.2 Related Reports 10
3 Disease Overview 12
3.1 Clinical Manifestations of Neuropathic Pain – Signs and Symptoms 14
3.1.1 Painful Diabetic Neuropathy 16
3.1.2 Postherpetic Neuralgia 17
3.1.3 Trigeminal Neuralgia 17
3.2 Etiology and Pathophysiology 18
3.2.1 Etiology 19
3.2.2 Pathophysiology 20
4 Disease Management 28
4.1 Diagnosis and Treatment Overview 28
4.1.1 Diagnosis 28
4.1.2 Treatment Overview and Guidelines 35
5 Competitive Assessment 45
5.1 Overview 45
6 Unmet Need and Opportunity 50
6.1 Overview 50
6.2 Physician Knowledge or Awareness 51
6.2.1 Unmet Need 51
6.2.2 Gap Analysis 52
6.2.3 Opportunity 53
6.3 Diagnostic Challenges 53
6.3.1 Unmet Need 53
6.3.2 Gap Analysis 54
6.3.3 Opportunity 54
6.4 Low Treatment Rate and Underdosing of Medications 54
6.4.1 Unmet Need 54
6.4.2 Gap Analysis 56
6.4.3 Opportunity 56
6.5 Unsatisfactory Efficacy and Safety Profiles of Pharmacological Treatments 57
6.5.1 Unmet Need 57
6.5.2 Gap Analysis 58
6.5.3 Opportunity 58
6.6 Elderly Patient Population – Drug Tolerability 59
6.6.1 Unmet Need 59
6.6.2 Gap Analysis 59
6.6.3 Opportunity 60
6.7 Rational or Personalized Therapies 60
6.7.1 Unmet Need 60
6.7.2 Gap Analysis 61
6.7.3 Opportunity 61
7 Pipeline Assessment 63
7.1 Overview 63
7.2 Promising Drugs in Clinical Development 64
8 Eladur (bupivacaine patch) 67
8.1 Overview 67
8.2 Efficacy 68
8.3 Safety 68
8.4 Dosing and Formulation 69
8.5 Potential Clinical and Commercial Positioning 69
8.6 Pricing and Reimbursement 69
8.7 SWOT Analysis 70
8.8 Forecast 70
9 Appendix 72
9.1 Bibliography 72
9.2 Abbreviations 76
9.3 Methodology 79
9.4 Forecasting Methodology 79
9.4.1 Diagnosed PDN, PHN, and TN Patients 79
9.4.2 Percent Drug-Treated Patients 80
9.4.3 General Pricing Assumptions 80
9.4.4 Generic Erosion 80
9.4.5 Pricing of Pipeline Agents 81
9.5 Physicians and Specialists Included in This Study 81
9.6 About the Authors 83
9.6.1 Author 83
9.6.2 Global Head of Healthcare 84
9.7 About GlobalData 85
9.8 Disclaimer 85

1.1 List of Tables
Table 1: Classification of NP Syndromes Based on the Site of Somatosensory Damage 14
Table 2: Signs and Symptoms of NP 15
Table 3: Screening Tools for NP 29
Table 4: NP-Related Signs and Symptoms 31
Table 5: Treatment Guidelines for NP 36
Table 6: Recommended Drug Therapies for NP Conditions by Line of Therapy 42
Table 7: Most Prescribed Drugs for NP by Indication and Line of Therapy in the Global Markets, 2012 44
Table 8: NNT and NNH for Classes of Oral Drugs used in NP Treatment, 2013 47
Table 9: Select Products Used for NP Treatment, 2013 49
Table 10: Unmet Need and Opportunity in NP 51
Table 11: NP - Promising Drugs in Clinical Development 65
Table 12: Comparison of Drugs in Development for NP, 2014 65
Table 13: Product Profile - Eladur 68
Table 14: Eladur SWOT Analysis, 2013 70
Table 15: Global Sales Forecasts ($) for Eladur, 2012-2022 71

1.2 List of Figures
Figure 1: Nociceptive Versus Neuropathic Pain 13
Figure 2: Etiology and Pathophysiology of NP 18
Figure 3: Pain Pathway - Somatosensory System 21
Figure 4: Pathophysiological Mechanisms of NP at Different Levels of the Nervous System 25
Figure 5: Pathophysiological Targets of NP Drugs 26
Figure 6: NeuSPIG Diagnostic Certainty Algorithm for NP 32
Figure 7: General Treatment Algorithm for NP 41
Figure 8: Competitive Assessment of Mid-to-Late Stage Pipeline Agents in NP, 2012-2022 66

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 透明バリア包装フィルムの北米市場
    About Transparent Barrier Packaging Films Transparent barrier packaging films are used for providing transparency to the product and protecting them from dust, gases, moisture, and aroma. Plastic resins such as biaxially oriented polypropylene (BOPP), polyvinyl chloride (PVC), polylactic acid (PLA), …
  • 世界及び中国のイソボルネオールパウダー市場2017
    The 'Global and Chinese Isoborneol Powder Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Isoborneol Powder industry with a focus on the Chinese market. The report provides key statistics on the market status of the Isoborneol Powde …
  • OTC医薬品(市販薬)の世界市場予測2016-2026
    What can be expected from the Over-the-Counter Pharmaceuticals Market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects. Our 247-page report provides 148 tables, charts, and graphs. Di …
  • ナトリウムメタリルスルホン酸(SMAS)の世界及び中国市場 2018年
    The 'Global and Chinese Sodium Methallyl Sulfonate(SMAS) Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Sodium Methallyl Sulfonate(SMAS) industry with a focus on the Chinese market. The report provides key statistics on the market …
  • 世界のサービスとしてのネットワーク市場2017
    Network-as-a-Service Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, G …
  • ガーナのプラスチック製包装製品市場(~2019):市場規模、動向、予測
    The report Plastic Packaging Product Market in Ghana to 2019 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook for plastic packaging products in Ghana. The research includes historic data from 2008 to 2014 and foreca …
  • 世界のスリーピース油圧チューブ継手市場2017
    Three Piece Hydraulic Tube Fitting Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (Un …
  • Enovation Resources Ltd(石油・ガス分野):企業M&A動向
    Summary Enovation Resources Ltd (Enovation) is an oil and gas exploration and production company. The company explores, produces, and develops oil and gas reserves. Enovation has its assets in Gulf of Mexico, the North Sea, and the Asia-Pacific regions. The company’s Gulf of Mexico asset holds West …
  • ゴム手袋市場:イタリア(市場規模、動向、予測~2018)
    This industry report offers the most up-to-date market data on the actual market situation, trends and future outlook for rubber gloves in Italy. The research includes historic market data from 2007 to 2013 and forecasts until 2018 which makes the report an invaluable resource for industry executive …
  • 農業荷造機の世界市場:販売動向2017
    Notes:Sales, means the sales volume of Agricultural Baling Press Revenue, means the sales value of Agricultural Baling Press This report studies sales (consumption) of Agricultural Baling Press in Global market, especially in United States, China, Europe and Japan, focuses on top players in these re …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDHC410DFR )"Eladur(神経因性疼痛):医薬品市場予測及び分析(~2022)" (英文:Eladur (Neuropathic Pain) - Forecast and Market Analysis to 2022)はGlobalData社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。